In summary, we found that CEBPG promoted ovarian tumor cell proliferation and inhibited ferroptosis in vitro and accelerated tumor growth in vivo, and the promotion of ovarian cancer by CEBPG is partially dependent on SLC7A11 (Fig. 8). The gene discussed is SLC7A11; the disease is ovarian carcinoma.